Cita APA (7a ed.)

A, M., M, S., U, B., M, S., & K, G. (2020). Incidence of ROS1-Rearranged Non-Small-Cell Lung Carcinoma in India and Efficacy of Crizotinib in Lung Adenocarcinoma Patients. Dove Medical Press.

Cita Chicago Style (17a ed.)

A, Mehta, Saifi M, Batra U, Suryavanshi M, y Gupta K. Incidence of ROS1-Rearranged Non-Small-Cell Lung Carcinoma in India and Efficacy of Crizotinib in Lung Adenocarcinoma Patients. Dove Medical Press, 2020.

Cita MLA (8a ed.)

A, Mehta, et al. Incidence of ROS1-Rearranged Non-Small-Cell Lung Carcinoma in India and Efficacy of Crizotinib in Lung Adenocarcinoma Patients. Dove Medical Press, 2020.